Anti–nerve growth factor therapy attenuates cutaneous hypersensitivity and musculoskeletal discomfort in mice with osteoporosis

INTRODUCTION: The prevalence of osteoporosis is increasing with the aging population and is associated with increased risk of fracture and chronic pain. Osteoporosis is currently treated with bisphosphonate therapy to attenuate bone loss. We previously reported that improvement in bone mineral densi...

Descripción completa

Detalles Bibliográficos
Autores principales: Suzuki, Miyako, Millecamps, Magali, Ohtori, Seiji, Mori, Chisato, Stone, Laura S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer 2018
Materias:
Basic Science
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999413/
https://www.ncbi.nlm.nih.gov/pubmed/29922744
http://dx.doi.org/10.1097/PR9.0000000000000652

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5999413/
https://www.ncbi.nlm.nih.gov/pubmed/29922744
http://dx.doi.org/10.1097/PR9.0000000000000652

Ejemplares similares